These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23378719)

  • 1. Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates.
    Hong P; Koza S; Bouvier ES
    J Liq Chromatogr Relat Technol; 2012 Nov; 35(20):2923-2950. PubMed ID: 23378719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-exclusion chromatography using reverse-phase columns for protein separation.
    Huang TY; Chi LM; Chien KY
    J Chromatogr A; 2018 Oct; 1571():201-212. PubMed ID: 30146374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Size-Exclusion Chromatography Method for Analysis of Clostridium difficile Vaccine Toxins.
    Lancaster C; Rustandi RR; Pannizzo P; Ha S
    Methods Mol Biol; 2016; 1476():279-87. PubMed ID: 27507349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size exclusion chromatography using large pore size media induces adverse conformational changes of inactivated foot-and-mouth disease virus particles.
    Song Y; Yang Y; Lin X; Zhao Q; Su Z; Ma G; Zhang S
    J Chromatogr A; 2022 Aug; 1677():463301. PubMed ID: 35809520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory and practice of size exclusion chromatography for the analysis of protein aggregates.
    Fekete S; Beck A; Veuthey JL; Guillarme D
    J Pharm Biomed Anal; 2014 Dec; 101():161-73. PubMed ID: 24816223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry.
    Murisier A; Fekete S; Guillarme D; D'Atri V
    Anal Chim Acta; 2021 Oct; 1183():338987. PubMed ID: 34627511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins.
    Goyon A; Fekete S; Beck A; Veuthey JL; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():368-378. PubMed ID: 29936373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric stationary phases for size exclusion chromatography: A review.
    Lubomirsky E; Khodabandeh A; Preis J; Susewind M; Hofe T; Hilder EF; Arrua RD
    Anal Chim Acta; 2021 Mar; 1151():338244. PubMed ID: 33608083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust quantitation of basic-protein higher-order aggregates using size-exclusion chromatography.
    Gervais D; Downer A; King D; Kanda P; Foote N; Smith S
    J Pharm Biomed Anal; 2017 May; 139():215-220. PubMed ID: 28292680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity.
    Gabrielson JP; Brader ML; Pekar AH; Mathis KB; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2007 Feb; 96(2):268-79. PubMed ID: 17080424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of a precolumn with size exclusion and reversed-phase modes for size-exclusion chromatographic analysis of polysorbate-containing protein aggregates.
    Fukuda J; Iura T; Yanagihara S; Kano K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():68-72. PubMed ID: 24576768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of size exclusion chromatography columns packed with sub-3μm particles for the analysis of biopharmaceutical proteins.
    Goyon A; Beck A; Colas O; Sandra K; Guillarme D; Fekete S
    J Chromatogr A; 2017 May; 1498():80-89. PubMed ID: 27914608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some Lessons Learned From a Comparison Between Sedimentation Velocity Analytical Ultracentrifugation and Size Exclusion Chromatography to Characterize and Quantify Protein Aggregates.
    Gandhi AV; Pothecary MR; Bain DL; Carpenter JF
    J Pharm Sci; 2017 Aug; 106(8):2178-2186. PubMed ID: 28479353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the limits of size exclusion chromatography: Simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregates.
    Goyon A; Sciascera L; Clarke A; Guillarme D; Pell R
    J Chromatogr A; 2018 Mar; 1539():19-29. PubMed ID: 29397979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved performance of protein separation by continuous annular chromatography in the size-exclusion mode.
    Iberer G; Schwinn H; Josić D; Jungbauer A; Buchacher A
    J Chromatogr A; 2001 Jun; 921(1):15-24. PubMed ID: 11461008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Size exclusion-reverse liquid column chromatography-mass spectrometry and its application in the identification of post-translationally modified proteins in rat kidney].
    Li J; Zhuo Y; Zhang Y; Li N; Wu J
    Se Pu; 2021 Jan; 39(1):87-95. PubMed ID: 34227362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hollow fiber flow field-flow fractionation and size-exclusion chromatography with MALS detection: A complementary approach in biopharmaceutical industry.
    Marassi V; Roda B; Zattoni A; Tanase M; Reschiglian P
    J Chromatogr A; 2014 Dec; 1372C():196-203. PubMed ID: 25468501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size exclusion chromatography of synthetic polymers and biopolymers on common reversed phase and hydrophilic interaction chromatography columns.
    Caltabiano AM; Foley JP; Barth HG
    J Chromatogr A; 2016 Mar; 1437():74-87. PubMed ID: 26877177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of interactions between antibody biotherapeutics and copper by size exclusion chromatography (SEC) coupled with inductively coupled plasma mass spectrometry (ICP/MS).
    Luo Y; Ronk M; Joubert MK; Semin D; Nashed-Samuel Y
    Anal Chim Acta; 2019 Nov; 1079():252-259. PubMed ID: 31387718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.